Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
2.LaVigne AW, Triedman SA, Randall TC, Trimble EL, Viswanathan AN (2017) Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery. Gynecol Oncol Rep 22:16–20. https://doi.org/10.1016/j.gore.2017.08.004
Article PubMed PubMed Central Google Scholar
3.Witsch E, Sela M, Yarden Y (2010) Roles for growth factors in cancer progression. Physiology (Bethesda Md) 25(2):85–101. https://doi.org/10.1152/physiol.00045.2009
4.Erdogan B, Webb DJ (2017) Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans 45(1):229–236. https://doi.org/10.1042/bst20160387
CAS Article PubMed PubMed Central Google Scholar
5.Liotta LA (1986) Tumor invasion and metastases–role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46(1):1–7
6.Liotta LA (2016) Adhere, degrade, and move: the three-step model of invasion. Cancer Res 76(11):3115–3117. https://doi.org/10.1158/0008-5472.Can-16-1297
CAS Article PubMed PubMed Central Google Scholar
7.Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365–393. https://doi.org/10.1146/annurev.cb.08.110192.002053
CAS Article PubMed Google Scholar
8.Kovalszky I, Nagy P, Szende B, Lapis K, Szalay F, Jeney A, Schaff Z (1998) Experimental and human liver fibrogenesis. Scand J Gastroenterol Suppl 228:51–55
9.Rapraeger AC (2000) Syndecan-regulated receptor signaling. J Cell Biol 149(5):995–998. https://doi.org/10.1083/jcb.149.5.995
CAS Article PubMed PubMed Central Google Scholar
10.Woods A, Couchman JR (1998) Syndecans: synergistic activators of cell adhesion. Trends Cell Biol 8(5):189–192
11.Beauvais DM, Rapraeger AC (2003) Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp Cell Res 286(2):219–232. https://doi.org/10.1016/s0014-4827(03)00126-5
CAS Article PubMed Google Scholar
12.Dobra K, Nurminen M, Hjerpe A (2003) Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells. Anticancer Res 23(3b):2435–2444
13.Jayson GC, Vives C, Paraskeva C, Schofield K, Coutts J, Fleetwood A, Gallagher JT (1999) Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer 82(2):298–304
14.Larrain J, Carey DJ, Brandan E (1998) Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J Biol Chem 273(48):32288–32296. https://doi.org/10.1074/jbc.273.48.32288
CAS Article PubMed Google Scholar
15.Mundhenke C, Meyer K, Drew S, Friedl A (2002) Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 160(1):185–194. https://doi.org/10.1016/s0002-9440(10)64362-3
CAS Article PubMed PubMed Central Google Scholar
16.Soukka T, Pohjola J, Inki P, Happonen RP (2000) Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med 29(7):308–313
17.Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L, Kovalszky I (2002) Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Sem Cancer Biol 12(3):173–186. https://doi.org/10.1016/s1044-579x(02)00021-4
18.Sobel G, Szabo I, Paska C, Kiss A, Kovalszky I, Kadar A, Paulin F, Schaff Z (2005) Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia. Pathol Oncol Res 11(1):26–31
19.Kurokawa H, Matsumoto S, Murata T, Yamashita Y, Tomoyose T, Zhang M, Fukuyama H, Takahashi T (2003) Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med 32(9):513–521
20.Inki P, Stenback F, Grenman S, Jalkanen M (1994) Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol 172(4):349–355. https://doi.org/10.1002/path.1711720410
CAS Article PubMed Google Scholar
21.Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C (2001) Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95(1):1–6
22.Rintala M, Inki P, Klemi P, Jalkanen M, Grenman S (1999) Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol 75(3):372–378. doi:https://doi.org/10.1006/gyno.1999.5595
CAS Article PubMed Google Scholar
23.Nakanishi K, Yoshioka N, Oka K, Hakura A (1999) Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3’ untranslated region. Int J Cancer 80(4):527–532
24.Numa F, Hirabayashi K, Kawasaki K, Sakaguchi Y, Sugino N, Suehiro Y, Suminami Y, Hirakawa H, Umayahara K, Nawata S, Ogata H, Kato H (2002) Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis. Int J Oncol 20(1):39–43
25.Kopper L, Sebestyen A (2000) Syndecans and the lymphoid system. Leuk Lymphoma 38(3–4):271–281. https://doi.org/10.3109/10428190009087018
CAS Article PubMed Google Scholar
26.Larrain J, Cizmeci-Smith G, Troncoso V, Stahl RC, Carey DJ, Brandan E (1997) Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J Biol Chem 272(29):18418–18424. https://doi.org/10.1074/jbc.272.29.18418
CAS Article PubMed Google Scholar
27.Mennerich D, Vogel A, Klaman I, Dahl E, Lichtner RB, Rosenthal A, Pohlenz HD, Thierauch KH, Sommer A (2004) Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer (Oxford, England: 1990) 40(9):1373–1382. https://doi.org/10.1016/j.ejca.2004.01.038
28.Stanley MJ, Stanley MW, Sanderson RD, Zera R (1999) Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 112(3):377–383. https://doi.org/10.1093/ajcp/112.3.377
CAS Article PubMed Google Scholar
29.Mukunyadzi P, Liu K, Hanna EY, Suen JY, Fan CY (2003) Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol 16(8):796–801. https://doi.org/10.1097/01.Mp.0000081731.17549.53
30.Leivonen M, Lundin J, Nordling S, von Boguslawski K, Haglund C (2004) Prognostic value of syndecan-1 expression in breast cancer. Oncology 67(1):11–18. https://doi.org/10.1159/000080280
CAS Article PubMed Google Scholar
31.Ito Y, Yoshida H, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A (2003) Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation. Histopathology 43(2):157–164
32.Mathe M, Suba Z, Nemeth Z, Tatrai P, Fule T, Borgulya G, Barabas J, Kovalszky I (2006) Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol 42(5):493–500. https://doi.org/10.1016/j.oraloncology.2005.10.003
CAS Article PubMed Google Scholar
33.Maeda T, Alexander CM, Friedl A (2004) Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 64(2):612–621
34.Szabo S, Xu Y, Romero R, Fule T, Karaszi K, Bhatti G, Varkonyi T, Varkonyi I, Krenacs T, Dong Z, Tarca AL, Chaiworapongsa T, Hassan SS, Papp Z, Kovalszky I, Than NG (2013) Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Arch 463(3):445–458. https://doi.org/10.1007/s00428-013-1426-0
CAS Article PubMed PubMed Central Google Scholar
35.Fule T, Csapo Z, Mathe M, Tatrai P, Laszlo V, Papp Z, Kovalszky I (2006) Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol Oncol 100(3):570–578. https://doi.org/10.1016/j.ygyno.2005.09.019
36.Hazelbag S, Fleuren GJ, Baelde JJ, Schuuring E, Kenter GG, Gorter A (2001) Cytokine profile of cervical cancer cells. Gynecol Oncol 83(2):235–243. https://doi.org/10.1006/gyno.2001.6378
CAS Article PubMed Google Scholar
37.Baghy K, Dezso K, Laszlo V, Fullar A, Peterfia B, Paku S, Nagy P, Schaff Z, Iozzo RV, Kovalszky I (2011) Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab Invest 91(3):439–451. https://doi.org/10.1038/labinvest.2010.172
CAS Article PubMed Google Scholar
38.Fullar A, Dudas J, Olah L, Hollosi P, Papp Z, Sobel G, Karaszi K, Paku S, Baghy K, Kovalszky I (2015) Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer 15:256. https://doi.org/10.1186/s12885-015-1272-3
CAS Article PubMed PubMed Central Google Scholar
39.Maeda T, Desouky J, Friedl A (2006) Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene 25(9):1408–1412. https://doi.org/10.1038/sj.onc.1209168
CAS Article PubMed Google Scholar
40.Yang N, Mosher R, Seo S, Beebe D, Friedl A (2011) Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility. Am J Pathol 178(1):325–335. https://doi.org/10.1016/j.ajpath.2010.11.039
CAS Article PubMed PubMed Central Google Scholar
41.Boutin EL, Sanderson RD, Bernfield M, Cunha GR (1991) Epithelial-mesenchymal interactions in uterus and vagina alter the expression of the cell surface proteoglycan, syndecan. Dev Biol 148(1):63–74.
Comments (0)